About
AAV-Based Optogenetic Gene Therapies for Ocular Diseases
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide TherapyChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
221
By Phase
EARLY_PHASE1: 2
By Status
RECRUITING: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07085533Lead Sponsor
Color Vision Loss and Retinal Changes Correlation, and a Novel Color Test
N/ARecruiting
200 participants
Started: Jun 4, 2025 · Completed: Sep 28, 2027
NCT06292650Lead Sponsor
Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients
EARLY_PHASE1Recruiting
12 participants
Started: Feb 25, 2024 · Completed: Dec 25, 2028
NCT06066008Lead Sponsor
Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients
EARLY_PHASE1Recruiting
9 participants
Started: Sep 25, 2022 · Completed: Oct 31, 2027
Locations (1)
Headquarters
Wuhan, China
Map
Loading map...